|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
|
Fig. 5. Model for combined effects of Shh signaling and PI3K on cell cycle
progression through Nmyc1 regulation in CGNP cultures. Previous work indicates
that Shh signaling induces expression of the proto-oncogene transcription
factor Nmyc1. Nmyc1 is necessary and sufficient for maintaining CGNP
proliferation. The present findings indicate that maintenance of Nmyc1 protein
levels in vitro is regulated in a Shh-independent manner. Our data support a
role for IGFR signaling in activation of the PI3K pathway, which inhibits
GSK3-mediated phosphorylation of Nmyc1 T50 and its subsequent degradation. The
kinase priming Nmyc1 for GSK3 phosphorylation, by acting at S54, remains to be
identified. Other growth factors (e.g. SDF-1) or cell-cell interactions (e.g.
via integrins) are candidates for PI3K regulation and inhibition of GSK3
activity in vivo. The combined effect of concerted Shh and PI3K activity is to
promote G1 progression and precisely control the timing of cell cycle
exit.
|
